-
1 Comment
CENTR Brands Corp is currently in a long term uptrend where the price is trading 25.2% above its 200 day moving average.
From a valuation standpoint, the stock is 89.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 133.7.
CENTR Brands Corp's total revenue rose by 182.9% to $341K since the same quarter in the previous year.
Its net income has dropped by 2.2% to $-727K since the same quarter in the previous year.
Finally, its free cash flow grew by 0.2% to $-803K since the same quarter in the previous year.
Based on the above factors, CENTR Brands Corp gets an overall score of 4/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | F |
CurrencyCode | EUR |
ISIN | CA15234A1030 |
Beta | -0.88 |
---|---|
Market Cap | 117K |
PE Ratio | 0.0 |
Target Price | None |
Dividend Yield | None |
CENTR Brands Corp. engages in the develops, markets, and sells Cannabidiol (CBD) beverage products in the United States. It offers CENTR CBD sparkling water, a non-alcoholic CBD-infused functional beverage; CENTR instant ready-to-mix with CBD and adaptogen powder; CENTR Enhanced, a citrus, zero calorie, nootropic and adaptogen sparkling water; and CENTR CBD drinking recipes. The company was founded in 2012 and is based in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 303.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025